. Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?. Curr Alzheimer Res. 2007 Sep;4(4):446-57. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics